TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: percent change of coronary blood flow in response to acetylcholine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Articular range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscular strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Articular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Waking time post-sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distress levels during sample collection
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of stool evacuation per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of times per week participants felt they emptied their bowels completely
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: %glucose >180mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: %glucose >126mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of perfused vessels (PPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microvascular flow index in small vessels (MFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency or reaction time in MCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lasting return to work (RTW)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: time until lasting RTW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to repeat surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sputum retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deaths related to sputum retention
Endpoint domain: Mortality/survival
Primary endpoint: Glucagon-induced glucose area under the curve (AUC0-90 minutes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transient elevations in serum hepatic aminotransferases
Endpoint domain: Adverse events/effects
Primary endpoint: Discontinuation before the end of the 7-day period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Consumption of non-prescribed pills (non-adherence)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reported levels of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median GCS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Median RASS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in need for supplemental oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: BMD loss in femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD loss in lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum TNFalpha levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma ET levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of diuretics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stay on study drug
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: global early mortality
Endpoint domain: Mortality/survival
Primary endpoint: peak enzyme release of creatine kinase-MB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative mediastinal and chest tube drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: abstinence rate at week-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first lapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Hb concentration at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean serum-ferritin concentration at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: burden
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: personal control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breastfeeding duration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Language performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hearing loss at 2000 HZ and 8000 HZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAR (Surface Area Reduction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma ferritin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of iron deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Predictive capacity of EuroCTO (CASTLE) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mini Nutritional Assessment (MNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Short Physical Performance Battery (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: competence scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain severity following surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of oral feeding initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative shoulder pain incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe pain occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid consumption (tramadol use)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Physician discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased frequency of intercourse
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in the area of the BR R2 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: catheterization time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of children in the maladjustment range
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean incision size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fractures of the veneering porcelain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: serum lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CK level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Continuous abstinence rate at week 9-12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous abstinence rate at week 9-26
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in anxiety and depressive disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Real-time pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of unsedated colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality rate in women aged 50-59
Endpoint domain: Mortality/survival
Primary endpoint: Mean sojourn time for women aged 40-49 and 50-59
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of diagnostic procedures for older women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of urine leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Development of urinary tract infections
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of completed bone mineral density testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Wall Motion Score Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regional Wall Motion Score Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: regional metabolic changes in the frontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: regional metabolic changes in the cerebellum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: regional metabolic changes in the putamen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: median number of rocuronium bolus requests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean change in SNOT-22 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in LK scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathological complete response (pCR) in the breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathological complete response (pCR) in the breast and nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade 3-4 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of delivering meaningful assistance for parental cigarette smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allergic reactions to crude peanut oil
Endpoint domain: Adverse events/effects
Primary endpoint: Mean area under the curve for FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average increase in morning and evening PEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Days and nights with symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cognitive depressive symptoms improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Parathyroid Hormone (PTH) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Synovial fluid IL-1β and IL-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: standard deviation of the normal‐to‐normal intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: high frequency spectral power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: low/high frequency spectral ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gastric emptying (GE) time for solid meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric emptying (GE) time for liquid meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postprandial glucose reduction (AUC(0-6 h))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PAF area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAF distance to the optic nerve head
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total oesophageal acid exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean NGAB duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean nocturnal gastric pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: SLE Responder Index 4 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe flare incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prednisone dose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of appropriate chest compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time without chest compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute mountain sickness
Endpoint domain: Mortality/survival
Primary endpoint: Severity of acute mountain sickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients reaching LDL-C target of less than 100 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thigh muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: clinical manifestations of CCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum IL-1β levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean surface area increase from tumor to wound surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean absolute surface area increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative calcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Day of discontinuation of calcium and vitamin D supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day of hospital discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Frequency of patient-provider YV discussion
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Increase in DNMT1 mRNA-positive neurons
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Decrease in APOBEC-3C mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increase in GADD45β mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increase in TET1 mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: new occurrences of corneal erosions, iritis/uveitis, or macular edema
Endpoint domain: Adverse events/effects
Primary endpoint: serious adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: net cost savings per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ratings of drug effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transit time of indocyanine green
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leakage of indocyanine green
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Staining patterns in scleral inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of tiers I-II contraceptive methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: perceived severity of claudication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: stair climbing ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: general health domain of the SF‐36v2
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: hard drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coital frequency
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean task completion times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total time spent in treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean number of appointments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Localized visual field deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Waist reduction of 5-10 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight loss of 4.9 kg at three months and 6.2 kg at six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in at least one cardiovascular risk factor by > or = 10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of preterm delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of antibiotic therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Visual analogue scale
Endpoint domain: Adverse events/effects
Primary endpoint: Gastric emptying delay in response to hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvements in measures
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean number of medication discrepancies per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BOP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean CAL values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child-Pugh score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Albumin levels improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Model for end-stage liver disease score stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCAT scores in ongoing care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PCAT scores in community orientation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PCAT scores in cultural competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: gross stereopsis at age six
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DFS increments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DFT increments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss through chest drains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total hemoglobin loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Convergent validity of the HT
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Discriminant validity with emotion recognition task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Predictive validity with social and occupational functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean change in bleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACF number at 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: numbers of adenomas plus hyperplastic polyps at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of polyps at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Insulin sensitivity as assessed by QUICKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lipoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in dysmenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of simulated patient visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eGFR preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Suturing scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical demand (NASA score)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue